114 related articles for article (PubMed ID: 19631832)
1. [One-year data from the REACH registry in Spain].
Suárez C; Polo IG; Ibáñez P
Med Clin (Barc); 2009 Sep; 132 Suppl 2():10-4. PubMed ID: 19631832
[TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. On behalf of Spain's REACH Registry].
Suárez C; Castillo J; Esmatjes E; Sala J; Cairols M; Montoto C; Barberá G;
Med Clin (Barc); 2009 Apr; 132(14):537-44. PubMed ID: 19393390
[TBL] [Abstract][Full Text] [Related]
3. [The REACH registry: baseline and 1-year results].
Esmatjes E; Blanco AJ
Med Clin (Barc); 2009 Sep; 132 Suppl 2():5-9. PubMed ID: 19631831
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacoeconomic analysis: results of the REACH registry].
Suárez C; Abadía C; Echevarria A
Med Clin (Barc); 2009 Sep; 132 Suppl 2():41-3. PubMed ID: 19631839
[TBL] [Abstract][Full Text] [Related]
5. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
[TBL] [Abstract][Full Text] [Related]
6. [Implications of the REACH registry for internal medicine].
Ramos Salado JL
Med Clin (Barc); 2009 Sep; 132 Suppl 2():34-7. PubMed ID: 19631837
[TBL] [Abstract][Full Text] [Related]
7. Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis.
Reid CM; Ademi Z; Nelson MR; Connor G; Chew DP; Shiel L; Smeath A; De Looze F; Steg PG; Bhatt DL; Liew D;
Med J Aust; 2012 Feb; 196(3):193-7. PubMed ID: 22339526
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
[TBL] [Abstract][Full Text] [Related]
9. [Implications of the REACH registry for neurologists].
Roquer J
Med Clin (Barc); 2009 Sep; 132 Suppl 2():30-3. PubMed ID: 19631836
[TBL] [Abstract][Full Text] [Related]
10. [Implications of the REACH registry for cardiologists].
de la Villa Redondo BG
Med Clin (Barc); 2009 Sep; 132 Suppl 2():15-20. PubMed ID: 19631833
[TBL] [Abstract][Full Text] [Related]
11. [Atherothrombosis: an excessively globalizing concept?].
Castillo J; Blanco M
Med Clin (Barc); 2009 Sep; 132 Suppl 2():2-4. PubMed ID: 19631830
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
[TBL] [Abstract][Full Text] [Related]
13. [Implications of the REACH registry for endocrinologists].
Alonso G
Med Clin (Barc); 2009 Sep; 132 Suppl 2():21-4. PubMed ID: 19631834
[TBL] [Abstract][Full Text] [Related]
14. Baseline characteristics of patients with cerebrovascular disease in the REACH registry: the Spanish contribution.
Suárez C;
Cerebrovasc Dis; 2007; 24 Suppl 1():89-95. PubMed ID: 17971643
[TBL] [Abstract][Full Text] [Related]
15. Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.
Ruff CT; Bhatt DL; Steg PG; Gersh BJ; Alberts MJ; Hoffman EB; Ohman EM; Eagle KA; Lip GY; Goto S;
Int J Cardiol; 2014 Jan; 170(3):413-8. PubMed ID: 24321327
[TBL] [Abstract][Full Text] [Related]
16. [Implications of the REACH registry for vascular surgery].
Alvarez-Fernández LJ; Vallina-Victorero Vázquez MJ; Ramos Gallo MJ; Santiago MV
Med Clin (Barc); 2009 Sep; 132 Suppl 2():25-9. PubMed ID: 19631835
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
[TBL] [Abstract][Full Text] [Related]
18. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year.
Sabouret P; Cacoub P; Dallongeville J; Krempf M; Mas JL; Pinel JF; Priollet P; Steg G; Taminau D; Montalescot G;
Arch Cardiovasc Dis; 2008 Feb; 101(2):81-8. PubMed ID: 18398391
[TBL] [Abstract][Full Text] [Related]
19. [Risk factor control and treatment of atherothrombosis. Spain REACH Registry].
Suárez C; Cairols M; Castillo J; Esmatjes E; Sala J; Llobet X; Palma JC;
Med Clin (Barc); 2007 Oct; 129(12):446-50. PubMed ID: 17953908
[TBL] [Abstract][Full Text] [Related]
20. One-year cardiovascular event rates in outpatients with atherothrombosis.
Steg PG; Bhatt DL; Wilson PW; D'Agostino R; Ohman EM; Röther J; Liau CS; Hirsch AT; Mas JL; Ikeda Y; Pencina MJ; Goto S;
JAMA; 2007 Mar; 297(11):1197-206. PubMed ID: 17374814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
